These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16828516

  • 1. A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in children.
    Holmes JM, Leske DA, Cole SR, Chandler DL, Repka MX, Nasolacrimal Duct Obstruction Questionnaire Study Group, Silbert DI, Tien DR, Bradley EA, Sala NA, Levin EM, Hoover DL, Klimek DL, Mohney BG, Laby DM, Lee KA, Enzenauer RW, Bacal DA, Mills MD, Beck RW, Pediatric Eye Disease Investigator Group.
    Ophthalmology; 2006 Sep; 113(9):1675-80. PubMed ID: 16828516
    [Abstract] [Full Text] [Related]

  • 2. Lithuanian version of nasolacrimal duct obstruction symptom scoring questionnaire. Cross-cultural adaptation and validation. Short- and long-term results.
    Jakštas T, Balsevičius T, Vaitkus S, Padervinskis E.
    Clin Otolaryngol; 2020 Nov; 45(6):857-861. PubMed ID: 32638550
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Validation of a symptom-score questionnaire and long- term results of endoscopic dacryocystorhinostomy.
    Penttila E, Smirnov G, Seppa J, Tuomilehto H, Kokki H.
    Rhinology; 2014 Mar; 52(1):84-9. PubMed ID: 24618634
    [Abstract] [Full Text] [Related]

  • 5. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM, Chandler DL, Repka MX, Hoover DL, Lee KA, Melia M, Rychwalski PJ, Silbert DI, Pediatric Eye Disease Investigator Group, Beck RW, Crouch ER, Donahue S, Holmes JM, Quinn GE, Sala NA, Schloff S, Wallace DK, Foster NC, Frick KD, Golden RP, Lambert SR, Tien DR, Weakley DR.
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [Abstract] [Full Text] [Related]

  • 6. Outcomes in children with nasolacrimal duct obstruction: Significance of persistent symptoms while stents are in place.
    Espinoza GM, Lueder GT.
    J AAPOS; 2007 Apr; 11(2):187-8. PubMed ID: 17416328
    [Abstract] [Full Text] [Related]

  • 7. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
    Pediatric Eye Disease Investigator Group, Repka MX, Chandler DL, Beck RW, Crouch ER, Donahue S, Holmes JM, Lee K, Melia M, Quinn GE, Sala NA, Schloff S, Silbert DI, Wallace DK.
    Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
    [Abstract] [Full Text] [Related]

  • 8. Use of the Masterka for complex nasolacrimal duct obstruction in children.
    Khatib L, Nazemzadeh M, Revere K, Katowitz WR, Katowitz JA.
    J AAPOS; 2017 Oct; 21(5):380-383. PubMed ID: 28917994
    [Abstract] [Full Text] [Related]

  • 9. A simple and evolutional approach proven to recanalise the nasolacrimal duct obstruction.
    Chen D, Ge J, Wang L, Gao Q, Ma P, Li N, Li DQ, Wang Z.
    Br J Ophthalmol; 2009 Nov; 93(11):1438-43. PubMed ID: 19416937
    [Abstract] [Full Text] [Related]

  • 10. The Microbiome of the Nasolacrimal System and Its Role in Nasolacrimal Duct Obstruction.
    Curragh DS, Bassiouni A, Macias-Valle L, Vreugde S, Wormald PJ, Selva D, Psaltis AJ.
    Ophthalmic Plast Reconstr Surg; 2020 Nov; 36(1):80-85. PubMed ID: 31809480
    [Abstract] [Full Text] [Related]

  • 11. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.
    Pediatric Eye Disease Investigator Group.
    Arch Ophthalmol; 2012 Jun; 130(6):730-4. PubMed ID: 22801833
    [Abstract] [Full Text] [Related]

  • 12. Changes of Visual Symptoms and Functions in Patients with and without Dry Eye after Lacrimal Passage Obstruction Treatment.
    Kamao T, Takahashi N, Zheng X, Shiraishi A.
    Curr Eye Res; 2020 Dec; 45(12):1590-1597. PubMed ID: 32321316
    [Abstract] [Full Text] [Related]

  • 13. Anisometropia and amblyopia in nasolacrimal duct obstruction.
    Kipp MA, Kipp MA, Struthers W.
    J AAPOS; 2013 Jun; 17(3):235-8. PubMed ID: 23602456
    [Abstract] [Full Text] [Related]

  • 14. Functional Versus Anatomical Nasolacrimal Obstruction: Are There Differences in Epiphora Severity, Symptoms, or Effects on Quality of Life?
    Shapira Y, Macri C, Selva D.
    Ophthalmic Plast Reconstr Surg; 2013 Jun; 38(6):567-570. PubMed ID: 35502798
    [Abstract] [Full Text] [Related]

  • 15. Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.
    Iandelli A, Carobbio ALC, Migliardi R, Catalani M, Mazzola F, Parrinello G, Peretti G, Canevari FR.
    Acta Otorhinolaryngol Ital; 2021 Jun; 41(3):248-254. PubMed ID: 34264918
    [Abstract] [Full Text] [Related]

  • 16. The Use of Stents in Children with Nasolacrimal Duct Obstruction Requiring Surgical Intervention: A Systematic Review.
    Tai ELM, Kueh YC, Abdullah B.
    Int J Environ Res Public Health; 2020 Feb 07; 17(3):. PubMed ID: 32046207
    [Abstract] [Full Text] [Related]

  • 17. Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction?
    Mehta S, Ying GS, Hussain A, Harvey JT.
    Orbit; 2018 Apr 07; 37(2):135-139. PubMed ID: 29040001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Perioperative use of intravenous dexamethasone in the management of congenital nasolacrimal duct obstruction with balloon dacryoplasty.
    Hussein MA, Lopez P.
    J AAPOS; 2018 Dec 07; 22(6):449-451. PubMed ID: 30342184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.